Prostaglandin E2 attenuates SR141716A-precipitated withdrawal in tetrahydrocannabinol-dependent mice (Q44368383)

2 December 2017

title

Prostaglandin E2 attenuates SR141716A-precipitated withdrawal in tetrahydrocannabinol-dependent mice (English)

1 reference

2 December 2017

0 references

0 references

1 reference

3

Hiroyuki Tanaka

1 reference

2 December 2017

author name string

Kusnandar Anggadiredja

1

1 reference

2 December 2017

Taku Yamaguchi

2

1 reference

2 December 2017

Yukihiro Shoyama

4

1 reference

2 December 2017

Shigenori Watanabe

5

1 reference

2 December 2017

Tsuneyuki Yamamoto

6

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

2 December 2017

1 reference

2 December 2017

volume

966

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

47-53

1 reference

Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A.

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

Effects of the cannabinoid CB(1) receptor antagonist, SR141716A, after Delta(9)-tetrahydrocannabinol withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

delta-9-tetrahydrocannabinol (THC) increases brain prostaglandins in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

Prostanoid receptors of the EP3 subtype mediate the inhibitory effect of prostaglandin E2 on noradrenaline release in the mouse brain cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

Abstinence symptoms following oral THC administration to humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

Abstinence symptoms following smoked marijuana in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

Evaluation of reinforcing capability of delta-9-tetrahydrocannabinol in rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

Regulation of noradrenaline overflow in rat cerebral cortex by prostaglandin E2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

Receptor mediation in cannabinoid stimulated arachidonic acid mobilization and anandamide synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

Effects of cannabinoids on the activities of mouse brain lipases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

Elevation of brain prostaglandin E2 levels in rodents by delta 1-tetrahydrocannabinol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

Clinical relevance of cannabis tolerance and dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

Naloxone-induced or postwithdrawal abstinence signs in ?9-Tetrahydrocannabinol-Tolerant rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

Changes in aggressive behavior during withdrawal from long-term marijuana use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

Failure to obtain "cannabis-directed behavior" and abstinence syndrome in rats chronically treated with cannabis sativa extracts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

Precipitated cannabinoid withdrawal is reversed by Delta(9)-tetrahydrocannabinol or clonidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

Suppression of naloxone-precipitated withdrawal jumps in morphine-dependent mice by stimulation of prostaglandin EP3 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

Possible involvement of the locus coeruleus in inhibition by prostanoid EP3 receptor-selective agonists of morphine withdrawal syndrome in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

Anandamide- and delta9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4 -methyl-1H-pyrazole-3-carboximide hydrochloride].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

Clonidine but not nifedipine prevents the release of noradrenaline during naloxone-precipitated opiate withdrawal: an in vivo microdialysis study in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

Distribution of the messenger RNA for the prostaglandin E receptor subtype EP3 in the mouse nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

Time-course of the effects of chronic delta 9-tetrahydrocannabinol on behaviour, body temperature, brain amines and withdrawal-like behaviour in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

Physical withdrawal in rats tolerant to delta 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

Cannabinoid withdrawal syndrome is reduced in pre-proenkephalin knock-out mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

Neurochemical activity of noradrenergic neurons and pituitary-adrenal response after naloxone-induced withdrawal: the role of calcium channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

Withdrawal-like behaviour induced by inhibitors of biogenic amine reuptake in rats treated chronically with ? 9-tetrahydrocannabinol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

Behavioral suppression induced by cannabinoids is due to activation of the arachidonic acid cascade in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

Role of cannabinoid receptor in the brain as it relates to drug reward

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2904169-0

10.1016/S0006-8993(02)04169-0

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference